Vertex names Jonathan Poole finance chief as Crinetics buy closes
Vertex Pharmaceuticals is appointing Jonathan Poole as CFO in connection with its $10 billion acquisition of Crinetics Pharmaceuticals. Poole is currently senior vice president of finance and will become executive vice president, finance.
By Colin KellaherVertex Pharmaceuticals is appointing a new chief financial officer in connection with the biotechnology company's $10 billion acquisition of Crinetics Pharmaceuticals.Vertex on Tuesday said Jonathan Poole, currently senior vice president of finance, will become executive vice presi…